DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 587-594

  Guo, X Q ^a   Wang, S J ^a,b   Zhang, L W ^a   Wang, X L ^a   Zhang, J H ^b   Guo, W ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Department of Cellular Analysis   (China)

Author keywords

DNA methylation; Esophageal precancerous conditions (EPC); Esophageal squamous cell carcinoma (ESCC); High risk area; Immunohistochemical staining

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P16;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; FEMALE; GENE DELETION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLASMA; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE SILENCING; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 38549181592     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Costello J.F. and Plass C.: Methylation matters. J. Med. Genet. 38(5): 285-303, 2001.
2. Tokugawa T., Sugihara H., Tani T. and Hattori T.: Modes of Silencing of p16 in Development of Esophageal Squamous Cell Carcinoma. Cancer Res. 62(17):4938-4944,2002.
3. Noguchi T., Takeno S., Kimura Y., et al.: FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Int. J. Mol. Med. 11(4):441-447, 2003.
4. Wang Y., Fang M.Z., Liao J., et al..: Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clin. Cancer Res. 9(14): 5257-5263,2003.
5. Zhang L., Lu W., Miao X., Xing D., Tan W., Lin D.: Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis. 24(6):1039-1044,2003.
6. Yue C.M., Deng D.J., Bi M.X., Guo L.P., Lu S.H.: Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J. Gastroenterol. 9(6):1174-1178, 2003.
7. Wong M.L., Tao Q., Fu L., et al..: Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int. J. Oncol. 28(3):767-773, 2006.
8. Hamiltion S.R., Aaltonen L.A.: Pathology and Genetics of Tumours of the digestive system Lyon: IARG Press. 2000,11-36.
9. Zöchbauer-Müller S., Fong K.M., Maitra A., et al..: 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 61(9):3581-3585, 2001.
10. Fan X., Inda M.M., Tunon T., Castresana J.S.: Improvement of the methylation specific PCR technical conditions for the detection of p16 promoter hypermethylation in small amounts of tumor DNA. Oncol. Rep. 9(1): 181-183, 2002.
11. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B.: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. PNAS. 93(18):9821-9826,1996.
12. Xing E.P., Nie Y., Wang L.D., Yang G.Y., Yang C.S.: Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis. 20(1):77-84,1999.
13. Bian Y.S., Osterheld M.C., Fontolliet C., Bosman F.T., Benhattar J.: p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology. 122(4):1113-1121,2002.
14. Hibi K., Koike M., Nakayama H., et al..: A cancer-prone case with a background of methylation of p16 tumor suppressor gene. Clin. Cancer Res. 9(3):1053-1056, 2003.
15. Lee E.J., Lee B.B., Kim J.W., et al..: Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma. Eur. J. Cancer. 42(7):972-980,2006.
16. Tanaka H., Shimada Y., Harada H., et al..: Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res. 58(15): 3429-3434, 1998.
17. Shapiro B., Chakrabarty M., Cohn E.M., and Leon S.A.: Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 51(11):2116-2120,1983.
18. Hibi K., Taguchi M., Nakayama H., et al..: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 7(10):3135-3138, 2001.
19. Nie Y., Liao J., Zhao X., et al..: Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis. 23(10):1713-1720, 2002.